Clinical Trials on Follicular Lymphoma
Total 9655 results
-
Nicole LamannaActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
National Cancer Institute (NCI)CompletedT-Cell Large Granular Lymphocytic Leukemia | Leukemia, T-Cell Large Granular LymphocyticUnited States
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicBelarus, Poland
-
Castleman Disease Collaborative NetworkWithdrawnHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph NodeUnited States
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Scripps Translational Science InstituteCue HealthActive, not recruitingImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsHIV Infections | Lymphoma | Leukemia | Cancer | Multiple Myeloma | Immunosuppression | Immunodeficiency | Transplant | Graft Versus Host Disease | Age-Related ImmunodeficiencyUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterAmgenCompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Precancerous/Nonmalignant ConditionUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Mature T-cell and Nk-cell NeoplasmsSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteReliable Cancer TherapiesTerminatedPain | Lymphoma | Cancer | Neoplasm Metastasis | Multiple Myeloma | Hematologic Malignancy | Tumor | Unresectable Malignant Neoplasm | Malignant Solid TumorUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Lymphoproliferative DisorderUnited States
-
Cancer Research UKCompletedLymphoma | Head and Neck Cancer | Gastric Cancer | Nonneoplastic Condition | Lymphoproliferative DisorderUnited Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedSarcoma | Lymphoma | Breast Cancer | Head and Neck Cancer | Metastatic Cancer | Non-melanomatous Skin CancerUnited States
-
Institut Paoli-CalmettesUnknownLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host DiseaseFrance
-
Abramson Cancer Center at Penn MedicineNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingHeart Failure | Lymphoma | Breast Cancer | Cardiomyopathies | Cardiotoxicity | Toxicity Due to ChemotherapyUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedLymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Plasma Cell NeoplasmUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownSarcoma | Lymphoma | Cervical Cancer | Nasopharyngeal Cancer | Pancreatic Cancer | Esophageal Cancer | Prostate Cancer | Hepatobiliary Cancer
-
University of California, DavisCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Precancerous/Nonmalignant Condition | Secondary Myelofibrosis | Multiple Myeloma and Malignant Plasma Cell NeoplasmsUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
AmgenNational Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Small Intestine Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
AstraZenecaRecruitingChronic Lymphocytic LeukemiaRomania
-
BeiGeneRecruitingCLLAustralia, United States, New Zealand, Korea, Republic of, Canada, Puerto Rico
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
AstraZenecaRecruiting
-
Acerta Pharma BVAstraZenecaActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
-
AstraZenecaActive, not recruiting
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLeukemia, Lymphocytic, Chronic, B-CellCanada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent T-Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
AstraZenecaParexelActive, not recruitingChronic Lymphocytic LeukemiaUnited States, France, Italy, Spain, Sweden, Canada, Denmark, Korea, Republic of, Brazil, Russian Federation, Taiwan, Germany, Australia, Netherlands, Finland, Norway, United Kingdom
-
Georgetown UniversityHackensack Meridian HealthActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Northwell HealthCompletedChronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheAbbVie; German CLL Study GroupActive, not recruitingLymphocytic Leukemia, ChronicUnited States, Spain, France, United Kingdom, Australia, Canada, Denmark, Germany, Italy, Brazil, Argentina, Estonia, New Zealand, Austria, Bulgaria, Croatia, Romania, Russian Federation, Poland, Switzerland, Mexico
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
The First Affiliated Hospital with Nanjing Medical...AstraZenecaRecruitingChronic Lymphocytic LeukemiaChina
-
Hoffmann-La RocheRecruitingChronic Lymphocytic LeukemiaSpain, Australia, Germany, United States, Italy, United Kingdom, France
-
AstraZenecaRecruiting